Brief: Imagion Biosystems Resumes Magsense Nanoparticle Manufacturing Capabilities
14/09/2026 04:29
BRIEF-Imagion Biosystems Resumes Magsense Nanoparticle Manufacturing Capabilities Sept 14 (Reuters) - Imagion Biosystems Ltd IBX.AX:
RESUMES MAGSENSE NANOPARTICLE MANUFACTURING CAPABILITIES
ENTERS MASTER SERVICE AGREEMENT WITH KEY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANISATION
Further company coverage: IBX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imagion Biosystems
See all newsBrief: Imagion Biosystems Resumes Magsense Nanoparticle Manufacturing Capabilities
Brief: Imagion Biosystems Secures AU$3.75M In Capital Raise Following FDA Clearance Of Phase 2 Clinical Trial
Brief: Imagion Biosystems Secures A$3.75 Million In Firm Commitments Under Capital Raising
Australia's Imagion Biosystems falls on discounted placement
Brief: Imagion Biosystems Seeks Trading Halt